capecitabine increased DFS in bc left after presurgery chemo

besa

http://medicalxpress.com/news/2015-12-capecitabine...

"Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results from the phase III CREATE-X clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12."